520 related articles for article (PubMed ID: 26653875)
1. The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery.
Corbo C; Molinaro R; Parodi A; Toledano Furman NE; Salvatore F; Tasciotti E
Nanomedicine (Lond); 2016 Jan; 11(1):81-100. PubMed ID: 26653875
[TBL] [Abstract][Full Text] [Related]
2. Research progress and application opportunities of nanoparticle-protein corona complexes.
Huang W; Xiao G; Zhang Y; Min W
Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776
[TBL] [Abstract][Full Text] [Related]
3. The protein corona and its effects on nanoparticle-based drug delivery systems.
Li H; Wang Y; Tang Q; Yin D; Tang C; He E; Zou L; Peng Q
Acta Biomater; 2021 Jul; 129():57-72. PubMed ID: 34048973
[TBL] [Abstract][Full Text] [Related]
4. Protein corona: Dr. Jekyll and Mr. Hyde of nanomedicine.
Fasoli E
Biotechnol Appl Biochem; 2021 Dec; 68(6):1139-1152. PubMed ID: 33007792
[TBL] [Abstract][Full Text] [Related]
5. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
6. The concept of bio-corona in modulating the toxicity of engineered nanomaterials (ENM).
Westmeier D; Stauber RH; Docter D
Toxicol Appl Pharmacol; 2016 May; 299():53-7. PubMed ID: 26592323
[TBL] [Abstract][Full Text] [Related]
7. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
Liu N; Tang M; Ding J
Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
[TBL] [Abstract][Full Text] [Related]
8. Protein corona: a new approach for nanomedicine design.
Nguyen VH; Lee BJ
Int J Nanomedicine; 2017; 12():3137-3151. PubMed ID: 28458536
[TBL] [Abstract][Full Text] [Related]
9. Protein corona, influence on drug delivery system and its improvement strategy: A review.
Guo F; Luo S; Wang L; Wang M; Wu F; Wang Y; Jiao Y; Du Y; Yang Q; Yang X; Yang G
Int J Biol Macromol; 2024 Jan; 256(Pt 2):128513. PubMed ID: 38040159
[TBL] [Abstract][Full Text] [Related]
10. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: A critical review.
Kopac T
Int J Biol Macromol; 2021 Feb; 169():290-301. PubMed ID: 33340622
[TBL] [Abstract][Full Text] [Related]
11. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.
Moraru C; Mincea M; Menghiu G; Ostafe V
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296
[TBL] [Abstract][Full Text] [Related]
12. The impact of protein corona on the biological behavior of targeting nanomedicines.
Farshbaf M; Valizadeh H; Panahi Y; Fatahi Y; Chen M; Zarebkohan A; Gao H
Int J Pharm; 2022 Feb; 614():121458. PubMed ID: 35017025
[TBL] [Abstract][Full Text] [Related]
13. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
[TBL] [Abstract][Full Text] [Related]
14. Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity.
Lee YK; Choi EJ; Webster TJ; Kim SH; Khang D
Int J Nanomedicine; 2015; 10():97-113. PubMed ID: 25565807
[TBL] [Abstract][Full Text] [Related]
15. Cancer Nano-Immunotherapy from the Injection to the Target: The Role of Protein Corona.
Mikelez-Alonso I; Aires A; Cortajarena AL
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947622
[TBL] [Abstract][Full Text] [Related]
16. The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system.
Xiao W; Gao H
Int J Pharm; 2018 Dec; 552(1-2):328-339. PubMed ID: 30308270
[TBL] [Abstract][Full Text] [Related]
17. Impact of protein coronas on nanoparticle interactions with tissues and targeted delivery.
Chou WC; Lin Z
Curr Opin Biotechnol; 2024 Feb; 85():103046. PubMed ID: 38103519
[TBL] [Abstract][Full Text] [Related]
18. Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy.
Khan S; Sharifi M; Gleghorn JP; Babadaei MMN; Bloukh SH; Edis Z; Amin M; Bai Q; Ten Hagen TLM; Falahati M; Cho WC
J Control Release; 2022 Aug; 348():127-147. PubMed ID: 35660636
[TBL] [Abstract][Full Text] [Related]
19. Interactions of cationic polystyrene nanoparticles with marine bivalve hemocytes in a physiological environment: Role of soluble hemolymph proteins.
Canesi L; Ciacci C; Fabbri R; Balbi T; Salis A; Damonte G; Cortese K; Caratto V; Monopoli MP; Dawson K; Bergami E; Corsi I
Environ Res; 2016 Oct; 150():73-81. PubMed ID: 27257827
[TBL] [Abstract][Full Text] [Related]
20. Bypassing Protein Corona Issue on Active Targeting: Zwitterionic Coatings Dictate Specific Interactions of Targeting Moieties and Cell Receptors.
Safavi-Sohi R; Maghari S; Raoufi M; Jalali SA; Hajipour MJ; Ghassempour A; Mahmoudi M
ACS Appl Mater Interfaces; 2016 Sep; 8(35):22808-18. PubMed ID: 27526263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]